H7N9 vaccine hopes
Source: Agencies |
November 15, 2013, Friday
|
Print Edition
Print Edition
The first human tests of experimental vaccines against the deadly H7N9 strain of avian flu has produced protective antibodies in the vast majority of recipients.
Encouraging results in early-stage trials were announced by Swiss drugmaker Novartis and Novavax, a biotech company based in Rockville, Maryland.
The H7N9 strain of avian flu emerged in China last winter and there had been 45 deaths from 137 confirmed cases this year as of late October, according to the World Health Organization.
Public health experts fear the virus could come storming back this winter.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
